Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2778)	6/16/2010 12:03:11 PM
From: Jibacoa	Read Replies (1) of 3722

ACUR is up 6% on low volume of < 0.1% its ADV. bigcharts.marketwatch.com The DG of the stock on April 23 was after a joint Advisory Committee meeting of the FDA questioned the effectiveness of niacin included in the current Acurox formulation but cited no concerns with the snorting and intravenous abuse limiting features of the product. Now ACUR and KG expect to submit an NDA for Acurox Tablets without niacin in early 2011.<g> bigcharts.marketwatch.com The ACTAY remains at $8 The short ratio came down some in the last month and is around 4x its ADV. It seems that with some good news the stock could double from present levels.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next